NIH-funded research NIH-funded research

Finding ways to eliminate HIV from the body.

Official title: Antagonize Host Survival and Immune Escape Mechanisms for Elimination of HIV Viral Reservoirs

Funded at Ohio State University · NIH-11035853 · Data updated 2026-11-12

This study is looking at how HIV stays in the body even when people are on treatment, and it aims to find new ways to get rid of the virus for good by understanding how HIV interacts with the immune system, especially focusing on a protein called Nef that helps infected cells survive.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startMarch 14, 2024
Project endFebruary 28, 2026
Funding year2024
Award (this year)$841,702
NIH project number1R56AI181631-01A1
Project IDNIH-11035853 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are currently on antiretroviral therapy but still have detectable viral reservoirs.

Less likely to help

Patients who are not infected with HIV or those who have advanced AIDS with significant comorbidities may not benefit from this research.

What this research studies

This research investigates how HIV persists in the body despite treatment and aims to identify new strategies to eliminate the virus. It focuses on understanding the interactions between HIV and the host's immune system, particularly the role of a viral protein called Nef in promoting the survival of infected cells. By targeting specific cellular mechanisms, the research seeks to enhance the death of HIV-infected cells and reduce viral reservoirs, potentially leading to a cure for HIV/AIDS.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively eliminate HIV from the body, offering hope for a cure.

How similar studies have gone: Previous research has shown promise in targeting viral proteins to enhance the elimination of HIV, indicating that this approach could be effective.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Zhu, Jian — Ohio State University
  • Study coordinator: Zhu, Jian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.